Jesse T. Davidson

cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity

Stephen T. Ferris, Vivek Durai, Renee Wu et al. · Nature · 2020 · 587 citations · Full text

Medicine, Immunology, Oncology +14

WDFY4 is required for cross-presentation in response to viral and tumor antigens

Derek J. Theisen, Jesse T. Davidson, Carlos G. Briseño et al. · Science · 2018 · 339 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Cryptic activation of an Irf8 enhancer governs cDC1 fate specification

Vivek Durai, Prachi Bagadia, Jeffrey M. Granja et al. · Nature Immunology · 2019 · 168 citations · Full text

Life Sciences, Genetics, Molecular Biology +11

Notch2-dependent DC2s mediate splenic germinal center responses

Carlos G. Briseño, Ansuman T. Satpathy, Jesse T. Davidson et al. · Proceedings of the National Academy of Sciences · 2018 · 84 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors

Mohammad Y. Zaidi, Alexandra G. Lopez‐Aguiar, Mary Dillhoff et al. · JAMA Surgery · 2018 · 80 citations

Medicine, Oncology, Surgery +17